Primary central nervous system lymphoma in Japan 1995–1999: changes from the preceding 10 years
- 1 June 2004
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 130 (6) , 351-356
- https://doi.org/10.1007/s00432-004-0547-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas.Journal of Neuro-Oncology, 2002
- Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexateInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Therapeutic management of primary central nervous system lymphoma: Lessons from prospective trialsAnnals of Oncology, 2000
- Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS LymphomaJournal of Clinical Oncology, 2000
- Primary central nervous system lymphoma in japan: a nationwide surveyInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Systemic chemotherapy with vincristine, cyclophosphamide, doxorubicin and prednisolone following radiotherapy for primary central nervous system lymphoma: a phase II study.Journal of Neuro-Oncology, 1999
- Short Intensive Primary Chemotherapy and Radiotherapy in Sporadic Primary CNS Lymphoma (PCL)International Journal of Radiation Oncology*Biology*Physics, 1998
- Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.Journal of Clinical Oncology, 1996
- Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcomeJournal of Neurosurgery, 1994
- Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315International Journal of Radiation Oncology*Biology*Physics, 1992